1967
DOI: 10.1001/archotol.1967.00760050165008
|View full text |Cite
|
Sign up to set email alerts
|

Deafness Due to Orally Administered Neomycin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
0

Year Published

1969
1969
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(6 citation statements)
references
References 7 publications
0
6
0
Order By: Relevance
“…Hear ing loss is one of the most serious potential toxic effects of neomycin ther apy [8,11,16,20]. The range of plasma neomycin concentrations associ ated with ototoxicity in adults is poorly defined [2,5,18].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hear ing loss is one of the most serious potential toxic effects of neomycin ther apy [8,11,16,20]. The range of plasma neomycin concentrations associ ated with ototoxicity in adults is poorly defined [2,5,18].…”
Section: Discussionmentioning
confidence: 99%
“…Neomycin is a potentially toxic drug which, like other aminoglycoside antibiotics, can cause deafness and kidney damage [8,11,20], In adults, neomycin is poorly absorbed from the gastrointestinal tract [5,17,23] but the extent of its absorption in infants with gastrointes tinal disease is unknown. The purpose of this communication is to report the oral absorption of neomycin in 2 premature infants with NEC.…”
mentioning
confidence: 99%
“…Despite these properties, which are particularly useful in treating type Ila, the compound has not achieved widespread use. This could be related to its major side effect of audio toxicity (Gibson, 1967;Greenwood, 1959;Halpern and Heller, 1961;Greenberg and Momary, 1965;King, 1962). Neomycin, if absorbed in quantity, can cause permanent deafness with oral treatment (several cases have been reported).…”
Section: D-thyroxinementioning
confidence: 99%
“…The toxic effect of aminoglycoside antibiotics on the inner ear has been known for a long time, not only after parenteral but also after oral or intra-articular administration (Ballantyne, 1983;Brummett, 1980;Engstrom and Kohonen, 1965;Gibson, 1967;Gonzalez and Ona, 1975). Topical applications have also caused lesions when these antibiotics were given intrabronchially by aerosols (Fuller, 1960) or as a wound irrigant (Kelly et al, 1969).…”
Section: Introductionmentioning
confidence: 99%